Showing results (221-230 of 348) with videos related to

Sort By:
Pageof 35
Klinische Padiatrie|February 12, 2010
Prevalence and incidence of endocrine disorders in children: results of a survey in Baden-Wuerttemberg and Bavaria (EndoPrIn BB) 2000-2001R Schweizer, G Blumenstock, K Mangelsdorf, et al.
Hormone Research|March 4, 1998
Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996D A Price, P Wilton, P Jönsson, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|November 25, 2010
Investigation of myostatin serum levels before and after a 6-month lifestyle intervention program in obese childrenS Ehehalt, R Schweizer, G Blumenstock, et al.
Applied Health Economics and Health Policy|May 8, 2013
Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndromeStefan Kaspers, Michael B Ranke, Donald Han, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 1999
Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth StudyM B Ranke, A Lindberg, P Chatelain, et al.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth StudyM B Ranke, A Lindberg, P Chatelain, et al.
Journal of Molecular Endocrinology|August 12, 2006
IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578TKlaus W Frommer, Katharina Reichenmiller, Burkhardt S Schutt, et al.
Hormone Research|March 17, 2001
Significance of basal IGF-I, IGFBP-3 and IGFBP-2 measurements in the diagnostics of short stature in childrenM B Ranke, R Schweizer, M W Elmlinger, et al.
Hormone Research|September 11, 2001
Relevance of IGF-I, IGFBP-3, and IGFBP-2 measurements during GH treatment of GH-deficient and non-GH-deficient children and adolescentsM B Ranke, R Schweizer, M W Elmlinger, et al.
Hormone Research|August 23, 2005
IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational ageMichael B Ranke, Richard Traunecker, David D Martin, et al.
Pageof 35